Symposium: The Gut Microbiota and Disease - Session II

Symposium: The Gut Microbiota and Disease - Session II

Tuesday, April 27, 2021 • 2:00 PM - 5:00 PM (EST)

 

Xiao-Ming Yin, MD, PhDChair
Xiao-Ming Yin, MD, PhD
Indiana University School of Medicine

Wenke Feng, PhDCo-Chair
Wenke Feng, PhD
University of Louisville

Maria Pilar Alcaide, PhDCo-Chair
Maria Pilar Alcaide, PhD
Tufts University School of Medicine

Jose Otero, MD, PhDCo-Chair
José Otero, MD, PhD
The Ohio State University

Session Description: Humans carry a vast number of bacteria and other microbiota species from birth, and you may be more bacteria than you are you.  An increasing importance of microbiota in human health and diseases has been recognized.  Whatever your research subjects are, chances are that they may be influenced by the microbiota.  This symposium will discuss the impact of gut microbiota on diseases ranging from neurodegeneration to diabetes, from the liver to the heart, and from the immune cells to the bone.

  • Chair - Welcome and Introductions
  • 2:00 PM - 2:30 PM
    Gut Microbiome and Cancer or Immune Response
    Giorgio Trinchieri, MD, PhD • National Cancer Institute
  • 2:35 PM - 3:05 PM
    The Microbiome-Brain-β Cell Axis in Metabolic Syndrome
    Rachel J. Perry PhD • Yale School of Medicine
  • 3:10 PM - 3:40 PM
    Dietary Metabolism, the Gut Microbiome and Cardiovascular Health
    Wai Hong Wilson Tang, MD • Cleveland Clinic Lerner College of Medicine/Case Western Reserve University
  • 3:45 PM - 4:15 PM
    Gut Microbiota and Neurodegeneration
    Ali Keshavarzian, MD • Rush University Medical Center
  • 4:20 PM - 4:50 PM
    A Gut Microbiota Dysregulates Osteoimmune Cross Talk in Postpubertal Skeletal Development
    Chad M. Novince, PhD, DDS • Medical University of South Carolina College of Dental Medicine
  • 4:55 PM - 5:00 PM
    Closing Remarks